200 related articles for article (PubMed ID: 12916862)
1. Hepatitis C virus (HCV) and lymphomagenesis.
Weng WK; Levy S
Leuk Lymphoma; 2003 Jul; 44(7):1113-20. PubMed ID: 12916862
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus - associated B cell non-Hodgkin's lymphoma.
Mihăilă RG
World J Gastroenterol; 2016 Jul; 22(27):6214-23. PubMed ID: 27468211
[TBL] [Abstract][Full Text] [Related]
3. HCV-associated lymphomas.
Fiorilli M; Mecucci C; Farci P; Casato M
Rev Clin Exp Hematol; 2003 Dec; 7(4):406-23. PubMed ID: 15129650
[TBL] [Abstract][Full Text] [Related]
4. Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis.
Forghieri F; Luppi M; Barozzi P; Maffei R; Potenza L; Narni F; Marasca R
Clin Dev Immunol; 2012; 2012():807351. PubMed ID: 22844326
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus infection in subsets of neoplastic lymphoproliferations not associated with cryoglobulinemia.
Luppi M; Grazia Ferrari M; Bonaccorsi G; Longo G; Narni F; Barozzi P; Marasca R; Mussini C; Torelli G
Leukemia; 1996 Feb; 10(2):351-5. PubMed ID: 8637247
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus drives the unconstrained monoclonal expansion of VH1-69-expressing memory B cells in type II cryoglobulinemia: a model of infection-driven lymphomagenesis.
Carbonari M; Caprini E; Tedesco T; Mazzetta F; Tocco V; Casato M; Russo G; Fiorilli M
J Immunol; 2005 May; 174(10):6532-9. PubMed ID: 15879157
[TBL] [Abstract][Full Text] [Related]
7. Lower expression of CD81 B-cell receptor in lymphoproliferative diseases associated with hepatitis C virus infection.
Cacoub P; Bourlière M; Hausfater P; Charlotte F; Khiri H; Toci S; Piette JC; Poynard T; Halfon P
J Viral Hepat; 2003 Jan; 10(1):10-5. PubMed ID: 12558906
[TBL] [Abstract][Full Text] [Related]
8. Lymphoproliferative diseases and hepatitis C virus infection.
Hausfater P; Rosenthal E; Cacoub P
Ann Med Interne (Paris); 2000 Feb; 151(1):53-7. PubMed ID: 10761563
[TBL] [Abstract][Full Text] [Related]
9. Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders.
Rosa D; Saletti G; De Gregorio E; Zorat F; Comar C; D'Oro U; Nuti S; Houghton M; Barnaba V; Pozzato G; Abrignani S
Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18544-9. PubMed ID: 16339892
[TBL] [Abstract][Full Text] [Related]
10. The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and Overt B-cell malignancy.
Dammacco F; Sansonno D; Piccoli C; Racanelli V; D'Amore FP; Lauletta G
Semin Liver Dis; 2000; 20(2):143-57. PubMed ID: 10946420
[TBL] [Abstract][Full Text] [Related]
11. Salivary gland B cell lymphoproliferative disorders in Sjögren's syndrome present a restricted use of antigen receptor gene segments similar to those used by hepatitis C virus-associated non-Hodgkins's lymphomas.
De Re V; De Vita S; Gasparotto D; Marzotto A; Carbone A; Ferraccioli G; Boiocchi M
Eur J Immunol; 2002 Mar; 32(3):903-10. PubMed ID: 11870635
[TBL] [Abstract][Full Text] [Related]
12. Splenic large B-cell lymphoma in patients with hepatitis C virus infection.
Takeshita M; Sakai H; Okamura S; Oshiro Y; Higaki K; Nakashima O; Uike N; Yamamoto I; Kinjo M; Matsubara F
Hum Pathol; 2005 Aug; 36(8):878-85. PubMed ID: 16112004
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus infection, mixed cryoglobulinemia, and non-Hodgkin's lymphoma: an emerging picture.
Dammacco F; Gatti P; Sansonno D
Leuk Lymphoma; 1998 Nov; 31(5-6):463-76. PubMed ID: 9922037
[TBL] [Abstract][Full Text] [Related]
14. Response to antiviral treatment in hepatitis C virus-associated marginal zone lymphomas.
Kelaidi C; Rollot F; Park S; Tulliez M; Christoforov B; Calmus Y; Podevin P; Bouscary D; Sogni P; Blanche P; Dreyfus F
Leukemia; 2004 Oct; 18(10):1711-6. PubMed ID: 15284859
[TBL] [Abstract][Full Text] [Related]
15. Pre-stimulation of CD81 expression by resting B cells increases proliferation following EBV infection, but the overexpression of CD81 induces the apoptosis of EBV-transformed B cells.
Park GB; Kim D; Park SJ; Lee HK; Kim JH; Kim YS; Park SG; Choi IH; Yoon SH; Lee YJ; Paeng S; Hur DY
Int J Mol Med; 2015 Dec; 36(6):1464-78. PubMed ID: 26498453
[TBL] [Abstract][Full Text] [Related]
16. The rheumatoid factor response in the etiology of mixed cryoglobulins associated with hepatitis C virus infection.
Sasso EH
Ann Med Interne (Paris); 2000 Feb; 151(1):30-40. PubMed ID: 10761560
[TBL] [Abstract][Full Text] [Related]
17. From hepatitis C virus infection to B-cell lymphoma.
Couronné L; Bachy E; Roulland S; Nadel B; Davi F; Armand M; Canioni D; Michot JM; Visco C; Arcaini L; Besson C; Hermine O
Ann Oncol; 2018 Jan; 29(1):92-100. PubMed ID: 29045541
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C Virus-Associated B-Cell Non-Hodgkin's Lymphoma: Clinical and Therapeutic Challenges.
Russi S; Sansonno L; Sansonno D
Curr Drug Targets; 2017; 18(7):766-771. PubMed ID: 26844565
[TBL] [Abstract][Full Text] [Related]
19. Splenic lymphoma with villous lymphocytes, mixed cryoglobulinemia and HCV infection: deciphering the role of HCV in B-cell lymphomagenesis.
Suarez F; Lefrere F; Besson C; Hermine O
Dig Liver Dis; 2007 Sep; 39 Suppl 1():S32-7. PubMed ID: 17936220
[TBL] [Abstract][Full Text] [Related]
20. From the pathogenesis to the cure of indolent B-cell lymphoproliferative disorders associated with hepatitis C virus infection: which role for direct-acting antivirals?
Visentini M; Fiorilli M; Casato M
Expert Rev Hematol; 2017 Aug; 10(8):719-727. PubMed ID: 28675071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
